Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Cancer Surgery
Removal of ewing's sarcoma
What the surgical removal of Ewing's sarcoma involves, including wide local excision and limb-salvage reconstruction, how surgery integrates with systemic chemotherapy and radiotherapy, comparative treatment costs across Turkey, the UK, US, and Germany, who is eligible for resection, expected recovery milestones, potential surgical risks, and how to select an accredited multidisciplinary oncology centre.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Cancer Surgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Removal of Ewing's Sarcoma
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Removal of Ewing's sarcoma in Turkey: what it is and how surgical resection works
The removal of Ewing's sarcoma is a specialised surgical procedure aimed at resecting a malignant bone or soft-tissue tumour with clear margins while preserving as much physical function and structural integrity as possible. Ewing's sarcoma is an aggressive cancer composed of small round cells that most commonly develops in the long bones of the limbs, the pelvis, the chest wall, or neighbouring soft tissues, predominantly affecting children, adolescents, and young adults. In modern surgical oncology, resection is never an isolated treatment; it serves as a central local control modality within an intensive multimodal programme combining induction chemotherapy, definitive surgery, and subsequent adjuvant treatment. For international patients seeking advanced surgical expertise abroad, understanding how surgical oncologists achieve tumour clearance and reconstruct affected limbs is essential. For an overview of comprehensive cancer care pathways and surgical capabilities, visit our guide to oncology treatments in Turkey.
The biological goal of surgical intervention is achieving an en bloc excision with an R0 margin status, meaning no microscopic tumour cells remain at the outer surgical boundaries. Prior to surgery, patients undergo several cycles of neoadjuvant chemotherapy to shrink the tumour, eradicate micrometastatic disease, and induce tumour necrosis. A favourable response to chemotherapy often creates a defined fibrous boundary around the mass, enabling surgical teams to perform limb-sparing resections rather than radical ablative operations whenever anatomically feasible.
How is surgical resection for Ewing's sarcoma performed?
The operation is a meticulous, multi-stage procedure tailored to the anatomical location and extent of the tumour. The patient is placed under general anaesthesia with advanced cardiovascular monitoring and, where indicated, intraoperative nerve monitoring to safeguard critical peripheral nerves. The surgical oncologist begins by excising the original biopsy tract along with the skin incision to eliminate any risk of tumour seeding along the previous needle pathway. The surgical team then navigates through healthy anatomical planes, dissecting surrounding muscles and soft tissues to expose the tumour without puncturing or exposing the neoplasm itself.
Once the diseased bone segment or soft-tissue mass is isolated with a cuff of normal tissue, it is excised en bloc. The reconstructive phase follows immediately. If a bone segment or joint has been removed, orthopaedic oncologists restore skeletal continuity using a modular metal endoprosthesis, an anatomical bone allograft, or a vascularised bone graft such as a fibular transfer. Intraoperative frozen sections may be assessed by pathologists to verify margin clearance before definitive hardware implantation. Surgical duration typically ranges between three and eight hours depending on anatomical complexity, with pelvic and spinal resections requiring extended operative time.
Does removal of Ewing's sarcoma work? What clinical evidence shows
Clinical oncology data and international treatment protocols, such as those established by the European Intergroup Cooperative Ewing's Sarcoma Study (EURO-E.W.I.N.G.) and the Children's Oncology Group (COG), demonstrate that complete surgical resection with clear margins provides the most reliable local disease control for resectable tumours. Achieving an R0 resection significantly reduces the risk of local recurrence compared with non-operative local management alone, particularly in extremity tumours where wide margins are technically achievable.
However, surgical resection addresses only local tumour burden. Because Ewing's sarcoma has a high propensity for microscopic haematogenous spread, surgery alone cannot produce long-term cure without systemic chemotherapy. Following resection, pathologists examine the removed tumour to calculate the percentage of necrosis induced by preoperative chemotherapy. Patients with 90 percent or greater tumour necrosis demonstrate significantly higher disease-free survival rates. For tumours located in anatomically constrained areas such as the pelvis or spine, achieving wide margins is more challenging, and multimodal regimens frequently combine surgical excision with postoperative radiotherapy to optimise local disease control.
Removal of Ewing's sarcoma cost in Turkey compared with the UK, US, and Germany
The cost of surgical treatment for Ewing's sarcoma varies according to anatomical location, the complexity of reconstruction, the type of endoprosthetic hardware required, and the duration of inpatient hospital care. The figures presented below reflect estimated overall ranges for surgical resection and reconstruction rather than binding clinic quotes. Each medical centre assesses the patient's diagnostic imaging and medical records before providing an individualised cost breakdown.
| Country | Approximate cost range |
|---|---|
| Turkey | €12,000 – €38,000 |
| United Kingdom | €28,000 – €75,000 |
| United States | €45,000 – €140,000 |
| Germany | €25,000 – €70,000 |
Factors influencing the final price include whether custom 3D-printed titanium implants or modular tumour prostheses are utilised, the requirement for microvascular tissue transfers, days spent in the intensive care unit (ICU), and blood transfusions. International treatment packages in Turkey generally include pre-operative imaging review, surgeon and anaesthetist fees, operating theatre costs, standard inpatient hospital accommodation, initial physical rehabilitation, and routine postoperative histopathological margin analyses. Additional cycles of systemic chemotherapy or radiation therapy are priced separately based on the tailored oncological protocol.
Surgical options: limb-sparing resection, reconstruction, or amputation?
The primary decision in surgical planning involves balancing local cancer eradication against long-term limb function. Modern surgical techniques allow limb-salvage surgery in approximately 85 to 90 percent of extremity Ewing's sarcoma cases, replacing amputations that were historically routine. The choice of local approach depends heavily on tumour size, relationship to major neurovascular structures, patient age, and skeletal maturity.
| Method | Best suited to | Typical limits |
|---|---|---|
| Limb-sparing resection with modular endoprosthesis | Extremity tumours where major neurovascular bundles remain uninvolved | Mechanical wear over decades; periodic revision surgery required in young patients |
| Biological reconstruction (allograft or autograft) | Paediatric and adolescent patients requiring anatomical preservation or joint salvage | Extended time to complete osseous union; risk of non-union or allograft fracture |
| Amputation or rotationplasty | Extensive tumours encasing major neurovascular structures or non-responsive to chemotherapy | Significant physical alteration; requires ongoing prosthetic adaptation and rehabilitation |
Surgical oncology requirements in sarcoma care differ markedly from other tumour surgeries. For instance, unlike soft tissue procedures such as lumpectomy where minimal healthy margins around breast tissue may suffice, bone sarcoma resection requires wider anatomical margins to prevent recurrence. Furthermore, similar to visceral oncological procedures like removal of colon cancer, Ewing's sarcoma requires careful staging and coordination with medical oncologists before any operative intervention.
Who is a candidate for Ewing's sarcoma resection?
A patient is considered a suitable candidate for surgical resection when imaging confirms that the primary tumour can be completely removed with negative margins without causing unacceptable neurological or vascular impairment. Good candidates have completed induction chemotherapy, have stable or responsive local disease, and demonstrate adequate cardiac, renal, and haematological recovery following cytotoxic treatments to tolerate extensive anaesthesia and major tissue healing.
Conversely, patients are generally not candidates for standard limb-sparing excision if the tumour directly encases circumferential neurovascular bundles that cannot be reconstructed, if severe local infection is present at the surgical site, or if systemic disease progression occurs unchecked despite multiple lines of chemotherapy. In cases where limb-salvage would leave a non-functional, painful extremity with positive margins, amputation or definitive radiotherapy without resection may be recommended by the multidisciplinary tumour board to ensure patient safety and disease control.
What to expect before and after surgery: functional recovery and imaging
Understanding realistic outcomes requires distinguishing between radiological oncological success and physical functional recovery. Postoperative imaging, including high-resolution MRI and CT scans, serves to confirm complete structural excision of the neoplasm and accurate placement of reconstructive implants. What visual photographs cannot show is internal muscular healing, nerve regeneration, and the gradual adaptation of biological bone grafts to mechanical stress.
Functional recovery is progressive and demands dedicated participation in physical therapy. Patients undergoing limb reconstruction with a modern modular prosthesis often begin non-weight-bearing joint motion within days of surgery to prevent joint stiffness and muscular atrophy. In growing children fitted with expandable growing prostheses, non-invasive lengthening procedures using external magnetic fields can be conducted in subsequent years without repeated major surgery, ensuring leg-length equality as the child matures.
Your hospital stay in Turkey and recovery milestones
Undergoing major tumour resection abroad requires adequate time for post-surgical healing, wound monitoring, and coordination with oncologists before long-distance travel. Patients are typically admitted to the hospital for seven to fourteen days, which includes one to two nights in the intensive care unit or high-dependency surgical ward for fluid management, continuous pain control, and neurovascular checks of the operated limb.
International patients should plan to remain in Turkey for three to five weeks in total. This timeframe allows the surgical team to monitor wound healing, manage closed-suction drains, remove surgical sutures or staples, initiate weight-bearing physical therapy, and evaluate final histopathology margin reports before clearing the patient to fly. Flying prematurely increases the risk of wound dehiscence and deep vein thrombosis.
Potential risks and complications of Ewing's sarcoma surgery
Surgical removal of bone and soft-tissue sarcomas is a major intervention that carries recognised clinical risks. Information from the National Health Service (NHS), the European Society for Medical Oncology (ESMO), and specialised musculoskeletal tumour registries highlights several key complications associated with extensive oncological resections:
- Surgical site infection: Chemotherapy-induced immunosuppression increases the risk of bacterial infection around endoprosthetic implants or biological grafts, occasionally requiring prolonged intravenous antibiotics or surgical debridement.
- Wound healing complications: Preoperative systemic therapy and tension over extensive incisions can lead to delayed wound healing or skin necrosis.
- Deep vein thrombosis (DVT) and pulmonary embolism: Immobility and major pelvic or lower-extremity surgery heighten thromboembolic risks, managed through prophylactic anticoagulation and compression stockings.
- Nerve or vascular injury: Dissection close to major nerve trunks can result in temporary or permanent numbness, muscle weakness, or foot drop.
- Mechanical implant failure: Modular endoprostheses may experience aseptic loosening, bushing wear, or structural fatigue over long periods, necessitating revision surgery.
- Positive margins and local recurrence: If microscopic examination identifies tumour cells at the specimen boundary, supplementary radiotherapy or re-excision is required.
How to choose a multidisciplinary surgical oncology hospital and red flags
Because Ewing's sarcoma is rare and biologically complex, treatment should only be undertaken at an accredited tertiary hospital with a dedicated sarcoma multidisciplinary team (MDT). The surgical team must include fellowship-trained orthopaedic oncologists and paediatric surgical specialists who routinely manage complex skeletal reconstructions. The hospital must feature an advanced surgical intensive care unit, dedicated musculoskeletal pathologists, and 24-hour interventional radiology support.
Red flags to watch out for include clinics that propose surgery without prior tumour board review, facilities lacking specialised oncological surgery units, quotes that fail to specify implant manufacturers or ICU coverage, and any healthcare provider promising guaranteed cures or risk-free limb preservation. To understand how medical travel and case evaluations are organised, review how it works. You can submit diagnostic imaging and pathology reports for review through our free quote service. Surgical resection is always one component of broader oncology treatments that include multi-agent chemotherapy regimens.
Questions to ask your surgical oncology team
Before consenting to surgery, discuss the following practical questions with your surgical oncologist:
- What surgical margin width do you anticipate achieving based on my latest post-chemotherapy MRI?
- Will my reconstruction use a modular endoprosthesis, an expandable implant, or a biological bone graft, and why?
- How many sarcoma resections and complex limb reconstructions does your surgical team perform each year?
- What is your team's protocol if intraoperative pathology reveals close or positive surgical margins?
- How will the timing of this surgery coordinate with my upcoming cycles of adjuvant chemotherapy?
- What specific precautions and wound care protocols are in place to prevent infections while blood counts are low?
- What degree of long-term physical mobility and weight-bearing can I realistically expect to regain?
Conditions treated with Removal of Ewing's Sarcoma
Hospitals with Oncology in Turkey
Frequently asked questions
The removal of Ewing's sarcoma is an oncological surgical procedure to excise a malignant bone or soft-tissue tumour with a boundary of healthy tissue (clear margins). It is typically carried out after induction chemotherapy to maximise local cancer control while preserving physical function.
Clinical evidence confirms that complete surgical removal with clear margins provides reliable local tumour control. Because Ewing's sarcoma is a systemic malignancy, surgery must be integrated with multi-agent chemotherapy to reduce distant recurrence and achieve favourable long-term disease control.
In Turkey, surgical resection and reconstruction generally costs between €12,000 and €38,000, compared with €28,000 to €75,000 in the UK. The final price depends on tumour location, the requirement for modular or custom endoprostheses, surgical duration, and intensive care stay.
Initial recovery involves hospitalisation for one to two weeks with monitored wound healing and gentle mobilisation. Postoperative imaging confirms complete tumour excision and hardware placement. Long-term functional recovery, supported by structured physical therapy, continues over six to twelve months.
Limb-sparing surgery preserves the limb using metallic endoprostheses or bone allografts when major nerves and blood vessels are intact. Amputation is considered only when tumours encase critical neurovascular structures or when negative margins cannot otherwise be safely achieved.
Major oncological surgery involves recognised risks, including wound infection, thromboembolism, nerve injury, and prosthetic complications. Performing the operation within a regulated tertiary hospital featuring an experienced sarcoma multidisciplinary team and advanced intensive care substantially helps manage these risks.
The operation is conducted under general anaesthesia, ensuring you feel nothing during surgery. Postoperative pain is systematically controlled with intravenous analgesia, regional nerve blocks, and oral painkillers, tapering gradually as tissue healing progresses over subsequent weeks.
Modern modular tumour endoprostheses typically function effectively for ten to twenty years. In younger or physically active patients, mechanical wear, aseptic loosening, or skeletal growth may eventually require surgical component revision or non-invasive implant lengthening over time.
Patients typically spend seven to fourteen days in hospital and should plan to remain in Turkey for three to five weeks in total. This period allows proper wound healing, surgical drain removal, and review of final pathology margins before air travel.
Local recurrence can occur if microscopic residual cells persist at surgical margins or tumour biology is especially aggressive. Following surgery, regular surveillance with MRI, chest CT scans, and ongoing chemotherapy regimens are essential to monitor and address any recurrent disease promptly.
Patient stories